510(k) Report

510(k) · Cleared

Cleared

ULTRApulse Alpha CO2 Laser System, Delivery Devices and Accessories

K233301510(k) SpecialCleared Dec 1, 202363-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lumenis Be, Ltd. · GEX Powered Laser Surgical Instrument

Cleared on Dec 1, 2023 after a 63-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Dec 1, 2023
Review
63 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K233301Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Modified ULTRApulse Alpha CO2 Laser System, Delivery Devices and Accessories (members of the UltraPulse CO2 Laser Systems Family) is indicated for use in surgical or aesthetic applications requiring: ablation, vaporization, excision, incision, or coagulation of soft tissue in medical specialties including: dermatology and plastic surgery (aesthetic), podiatry, gynecology, general and thoracic surgery, dental and oral surgery and genitourinary surgery…

Read the full statement (784 words)

The Modified ULTRApulse Alpha CO2 Laser System, Delivery Devices and Accessories (members of the UltraPulse CO2 Laser Systems Family) is indicated for use in surgical or aesthetic applications requiring:

ablation, vaporization, excision, incision, or coagulation of soft tissue in medical specialties including: dermatology and plastic surgery (aesthetic), podiatry, gynecology, general and thoracic surgery, dental and oral surgery and genitourinary surgery as follows:

Dermatology & Plastic Surgery

The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of:

• Laser skin resurfacing

• Laser derm-abrasion

• Laser burn debridement

-Laser skin resurfacing (ablation and/or vaporization) for treatment of:

• Wrinkles, rhytids, and furrows (including fine lines and texture irregularities).

-Laser skin resurfacing (ablation and/or vaporization) of soft tissue for the reduction, removal, and/or treatment of:

• Keratoses, including actinic and seborrheic keratosis, seborrhoecae vulgares, seborrheic wart and verruca seborrheica.

• Vermillionectomy of the lip

• Cutaneous horns

• Solar/actinic elastosis

• Cheilitis, including actinic cheilitis

• Lentigines, including lentigo maligna or Hutchinson's malignant freckle

• Uneven pigmentation/dyschromia

• Acne scars

• Surgical scars

• Keloids including acne keloidalis nuchae

• Hemangiomas (including Buccal, port wine and pyogenic granulomas/granuloma pyogenicum/granuloma telangiectaticum)

• Tattoos

• Telangiectasia

• Removal of small skin tumors, including periungual (Koenen) and subungual fibromas

• Superficial pigmented lesions

• Adenosebaceous hypertrophy or sebaceous hyperplasia

• Rhinophyma reduction

• Cutaneous papilloma (skin tags)

• Milia

• Debridement of eczematous or infected skin

• Basal and squamous cell carcinoma, including keratoacanthomas, Bowen's disease (Erythroplasia of Queyrat), and Bowenoid Papulosis (BP) lesions

• Nevi, including spider, epidermal and protruding

• N eurofibromas

• Laser de-epithelialization

• Tricoepitheliomas

• Xanthelasma palpebrarum

* Syringoma

-Laser ablation, vaporization and/or excision for complete and partial nail matrixectomy.

-Vaporization or coagulation of:

* Benign and malignant vascular/avascular skin lesions

* Moh's Surgery

* Lipectomy

* Verrucae and seborrhoecae vulgares, including paronychial, periungal, and subungual warts

-Laser incision and/or excision of soft tissue for the performance of upper and lower eyelid blepharoplasty.

-Laser incision and/or excision of soft tissue for the creation of recipient sites for hair transplantation

Podiatry

Laser ablation, vaporization, and/or excision of soft tissue for the reduction, removal, and/or treatment of:

* Verrucae vulgares/plantar (warts), including paronychial, periungal and subungual warts

* Porokeratoma ablation

* Ingrown nail treatment

* Neuromas/fibromas, including Morton’s neuroma

* Debridement of ulcers

* Other soft tissue lesions

Laser ablation, vaporization, and/or excision for complete and partial matrixectomy

Gynecology (GYN)

Laser incision, excision, ablation and/or vaporization of soft tissue in gynecology for the treatment of:

* vulvar and vaginal intraepithelial neoplasia (VIN, VAIN)

* Condyloma acuminata, including genital, vulvar, perineal, and Bowen’s disease (Erythrolasia of Queyrat) and Bowenoid papulosa (BP) lesions

* Leukoplakia (vulvar dystrophies)

* Incision and drainage (1&D) of Bartholin’s and nubuthian cysts

* Herpes vaporization

* Urethral caruncle vaporization

* Benign and malignant tumors

* Hemangiomas

General Surgery

Debridement of traumatic wounds

Debridement of decubitus and diabetic ulcers

* Microsurgery

* Artificial joint revision

* PMMA removal

General and Thoracic Surgery

Incision, excision and vaporization of soft tissue in general and thoracic surgery including endoscopic and open procedures. Applications include:

» Debridement of decubitus ulcers, stasis, diabetic, and other ulcers

* Mastectomy

* Debridement of burns

* Rectal and anal hemorrhoidectomy

* Breast biopsy

* Reduction mammoplasty

* Cytoreduction for metastatic disease

* Laparotomy applications

* Mediastinal and thoracic lesions and abnormalities

» Skin tag vaporization

* Atheroma

* Cysts, including sebaceous cysts, pilar cysts, and mucous cysts of the lips

* Pilonidal cyst removal and repair

* Abscesses

* Other soft tissue applications

Dental and Oral Surgery

Incision/excision and vaporization of soft tissue in dentistry and oral surgery. Applications include:

* Gingivectomy/removal of hyperplasias

* Gingivoplasty

* Incisional and excisional biopsy

* Treatment of ulcerous lesions, including aphthous ulcers

* Incision of infection when used with antibiotic therapy

* Frenectomy (frenum release)

* Excision and ablation of benign and malignant lesions

* Homeostasis

* Operculectomy

* Crown lengthening

» Removal of soft tissue, cysts and tumors

* Oral cavity tumors and hemangiomas

* Abscesses

* Extraction site hemostasis

+ Salivary gland pathologies

* Preprosthetic gum preparation

* Leukoplakia

* Partial glossectomy

* Periodontal gum resection

Genitourinary

Incision/excision and vaporization of soft tissue in genitourinary procedures. Applications include:

* Benign and malignant lesions of external genitalia

* Condyloma

* Phimosis

* Erythroplasia

The Lumenis Be modified ULTRApulse Alpha CO2 Laser System, Delivery Devices and Accessories when used in conjunction with FemTouch and FemX, is indicated for the vaporization, incision, excision, ablation and coagulation of body soft tissue in medical specialties including aesthetic (dermatology and plastic surgery), podiatry, gynecology, general and thoracic surgery. The use with the scanning unit is indicated for ablative skin resurfacing.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K233301: ULTRApulse Alpha CO2 Laser System, Delivery Devices and Accessories.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233301

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026